Use of Adaptol in the Treatment of Attention Deficit Hyperactivity Disorder in Children

The efficacy of Adaptol (a non-benzodiazepine tranquilizer) in the treatment of children with attention deficit hyperactivity disorder (ADHD) was studied. At a dose of 500 mg twice daily for one month, Adaptol decreased hyperactivity and impulsivity without producing significant changes in attention or reaction times (the authors emphasize the importance of this factor, as we are dealing with side effects often encountered when benzodiazepine tranquilizers are used). These results lead to the conclusion that Adaptol can be used in the treatment of ADHD as monotherapy in cases in which there is a predominance of hyperactivity/impulsivity and as a component of complex therapy in other types of the disorder, particularly when ADHD is combined with anxiety disorders.